![Ivacaftor / Phenols / Quinolones / Pharmaceuticals policy / Cystic fibrosis / Pharmaceutical Benefits Scheme / Vertex Pharmaceuticals / Eculizumab / Alternative medicine / Health / Medicine / Anilides Ivacaftor / Phenols / Quinolones / Pharmaceuticals policy / Cystic fibrosis / Pharmaceutical Benefits Scheme / Vertex Pharmaceuticals / Eculizumab / Alternative medicine / Health / Medicine / Anilides](https://www.pdfsearch.io/img/02365572b2ab9fafa46038a95f93e4f8.jpg)
| Document Date: 2014-10-25 23:32:46 Open Document File Size: 98,21 KBShare Result on Facebook
Company Vertex Pharmaceuticals / Alexion / / Country Australia / / Currency USD / / IndustryTerm treatment for cystic fibrosis / treatment for atypical Haemolytic Uraemic Syndrome / / MedicalCondition diseases / ultra-rare disease / atypical Haemolytic Uraemic Syndrome / cystic fibrosis G551D / prostate cancer / cystic fibrosis / / Organization Pharmaceutical Benefits Advisory Committee / / Person Peter Dutton / / / Position HEALTH MINISTER / MP MINISTER / / Product SOLIRIS / /
SocialTag |